Glutaminyl Cyclase Inhibitor 3 (compound 212) is a potent inhibitor of human glutaminyl cyclase (QC) with an IC50 value of 4.5 nM, exhibiting therapeutic potential for Alzheimer's disease by significantly reducing brain Aβ levels and restoring cognitive function.